Experimental evaluation of early and long-term effects of microparticle embolization in two different mini-pig models. Part II: Liver

CardioVascular and Interventional Radiology

Volumn 30, Issue 3, 2007, Pages 462-468

  Stampfl, S ^a   Stampfl, U ^a   Rehnitz, C ^a   Schnabel, Ph ^a   Satzl, S ^a   Christoph, P ^a   Henn, C ^a   Thomas, F ^a   Richter, G M ^a  

^a UNIVERSITY OF HEIDELBERG   (Germany)

Author keywords

Embolization; Embosphere; Inflammatory reaction; Trisacryl gelatin microspheres

Indexed keywords

MICROSPHERE; TRISACRYL GELATIN MICROSPHERE; UNCLASSIFIED DRUG;

ANGIOGRAPHY; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; ARTIFICIAL EMBOLISM; BILE DUCT; BIOASSAY; BLOOD VESSEL WALL; CELL INFILTRATION; CONTROLLED STUDY; FOLLOW UP; FOREIGN BODY REACTION; GIANT CELL; INFLAMMATION; LEUKOCYTE; LIVER; LIVER NECROSIS; LIVER PARENCHYMA; LIVER SINUSOID; MICROSCOPY; NONHUMAN; PRIORITY JOURNAL; VASCULAR FIBROSIS;

ACRYLIC RESINS; ANIMALS; EMBOLIZATION, THERAPEUTIC; FOREIGN-BODY MIGRATION; FOREIGN-BODY REACTION; GELATIN; HEPATIC ARTERY; LIVER; SWINE; SWINE, MINIATURE;

EID: 34247142528     PISSN: 01741551     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00270-005-0350-3     Document Type: Article

References (38)

1. Pelletier G, Roche A, Ink O, Anciaux ML, Derhy S, Rougier P, Lenoir C, Attali P, Etienne JP (1990) A randomized trial of hepatic arterial chemoembolization in patients with unresectable hepatocellular carcinoma. J Hepatol 11:181-184
2. Pelletier G, Ducreux M, Gay F, Luboinski M, Hagege H, Dao T, Van Steenbergen W, Buffet C, Rougier P, Adler M, Pignon JP, Roche A (1998) Treatment of unresectable hepatocellular carcinoma with lipiodol chemoembolization: A multicenter randomized trial. Groupe CHC. J Hepatol 29:129-134
3. Llovet JM (2005) Updated treatment approach to hepatocellular carcinoma. J Gastroenterol 40:225-235
4. Uraki J, Yamakado K, Nakatsuka A, Takeda K (2004) Transcatheter hepatic arterial chemoembolization for hepatocellular carcinoma invading the portal veins: Therapeutic effects and prognostic factors. Eur J Radiol 51:12-18
5. Bronowicki JP, Vetter D, Dumas F, Boudjema K, Bader R, Weiss AM, Wenger JJ, Boissel P, Bigard MA, Doffoel M (1994) Transcatheter oily chemoembolization for hepatocellular carcinoma. A 4-year study of 127 French patients. Cancer 74:16-24
6. Ikeda K, Kumada H, Saitoh S, Arase Y, Chayama K (1991) Effect of repeated transcatheter arterial embolization on the survival time in patients with hepatocellular carcinoma. An analysis by the Cox proportional hazard model. Cancer 68:2150-2154
7. Cheng HY, Shou Y, Wang X, Xu AM, Chen D, Jia YC (2004) Adjustment of lipiodol dose according to tumor blood supply during transcatheter arterial chemoembolization for large hepatocellular carcinoma by multidetector helical CT. World J Gastroenterol 10:2753-2755
8. Huppert PE, Lauchart W, Duda SH, Torkler C, Kloska SP, Weinlich M, Benda N, Pereira P, Claussen CD (2004) Chemoembolization of hepatocellular carcinomas: Which factors determine therapeutic response and survival? Rofo 176:375-385
9. Poyanli A, Rozanes I, Acunas B, Sencer S (2001) Palliative treatment of hepatocellular carcinoma by chemoembolization. Acta Radiol 42:602-607
10. Chen MS, Li JQ, Zhang YQ, Lu LX, Zhang WZ, Yuan YF, Guo YP, Lin XJ, Li GH (2002) High-dose iodized oil transcatheter arterial chemoembolization for patients with large hepatocellular carcinoma. World J Gastroenterol 8:74-78
11. Baur M, Walter R, Gebauer A, Tscholakoff D, Lochs H, Muhlbacher F, Turetschek K, Binder R, Hudec M, Gangl A, Ferenci P, Dittrich C (2003) Chemoembolization with cisplatin, lipiodol and Gelfoam and subsequent systemic chemotherapy with cisplatin and interferon in patients with hepatocellular carcinoma: A non-randomized prospective study. Int J Oncol 23:811-819
12. Caturelli E, Siena DA, Fusilli S, Villani MR, Schiavone G, Nardella M, Balzano S, Florio F (2000) Transcatheter arterial chemoembolization for hepatocellular carcinoma in patients with cirrhosis: Evaluation of damage to nontumorous liver tissue-long-term prospective study. Radiology 215:123-128
13. Harris M, Gibbs P, Cebon J, Jones R, Sewell R, Schelleman T, Angus P (2001) Hepatocellular carcinoma and chemoembolization. Intern Med J 31:517-522
14. Huang MS, Lin Q, Jiang ZB, Zhu KS, Guan SH, Li ZR, Shan H (2004) Comparison of long-term effects between intra-arterially delivered ethanol and Gelfoam for the treatment of severe arterioportal shunt in patients with hepatocellular carcinoma. World J Gastroenterol 10:825-829
15. Brown KT, Nevins AB, Getrajdman GI, Brody LA, Kurtz RC, Fong Y, Blumgart LH (1998) Particle embolization for hepatocellular carcinoma. J Vasc Interv Radiol 9:822-828
16. Pelage JP, Le Dref O, Beregi JP, Nonent M, Robert Y, Cosson M, Jacob D, Truc JB, Laurent A, Rymer R (2003) Limited uterine artery embolization with tris-acryl gelatin microspheres for uterine fibroids. J Vasc Interv Radiol 14:15-20
17. Beaujeux R, Laurent A, Wassef M, Casasco A, Gobin YP, Aymard A, Rufenacht D, Merland JJ (1996) Trisacryl gelatin microspheres for therapeutic embolization. II. Preliminary clinical evaluation in tumors and arteriovenous malformations. AJNR Am J Neuroradiol 17:541-548
18. Spies JB, Benenati JF, Worthington-Kirsch RL, Pelage JP (2001) Initial experience with use of tris-acryl gelatin microspheres for uterine artery embolization for leiomyomata. J Vasc Interv Radiol 12:1059-1063
19. Basile A, Rand T, Lomoschitz F, Toma C, Lupattelli T, Kettenbach J, Lammer J (2004) Trisacryl gelatin microspheres versus polyvinyl alcohol particles in the preoperative embolization of bone neoplasms. Cardiovasc Intervent Radiol. 27:495-502
20. Joffre FTJ, Pelage JP, Groupe FEMIC (2004) FEMIC (Fibromes Embolises aux MICrospheres calibrees): Uterine fibroid embolization using tris-acryl microspheres. A French multicenter study. Cardiovasc Intervent Radiol 27:600-606
21. Stampfl S, Stampfl U, Rehnitz C, Schnabel Ph, Satzl S, Christoph P, Henn C, Thomas F, Richter GM (2007) Experimental evaluation of early and long-term effects of microparticle embolization in two different mini-pig models. Part 1: Kidney. CVIR 30:257-267
22. Kassissia I, Brault A, Huet PM (1994) Hepatic artery and portal vein vascularization of normal and cirrhotic rat liver. Hepatology 19:1189-1197
23. Tancredi T, McCuskey PA, Kan Z, Wallace S (1999) Changes in rat liver microcirculation after experimental hepatic arterial embolization: Comparison of different embolic agents. Radiology 211:177-181
24. Kan Z, Ivancev K, Lunderquist A, McCuskey PA, Wright KC, Wallace S, McCuskey RS (1993) In vivo microscopy of hepatic tumors in animal models: A dynamic investigation of blood supply to hepatic metastases. Radiology 187:621-626
25. Ackerman NB (1974) The blood supply of experimental liver metastases. IV. Changes in vascularity with increasing tumor growth. Surgery 75:589-596
26. Itsubo M, Koike K, Tsuno S, Osada M, Komuro O, Shimada N, Okuda J, Fukada H, Okuaki Y, Kawabe T, Toda G (2002) Subsegmental transcatheter arterial embolization for small hepatocellular carcinoma. Hepatogastroenterology 49:735-739
27. Takayasu K, Shima Y, Muramatsu Y, Moriyama N, Yamada T, Makuuchi M, Hasegawa H, Hirohashi S (1987) Hepatocellular carcinoma: Treatment with intraarterial iodized oil with and without chemotherapeutic agents. Radiology 163:345-351
28. Lee JK, Chung YH, Song BC, Shin JW, Choi WB, Yang SH, Yoon HK, Sung KB, Lee YS, Suh DJ (2002) Recurrences of hepatocellular carcinoma following initial remission by transcatheter arterial chemoembolization. J Gastroenterol Hepatol 17:52-58
29. Chung YH (2005) A strategy for early detection of recurrent hepatocellular carcinoma following initial remission by transcatheter arterial chemoembolization. Intervirology 48:46-51
30. Ikeda M, Maeda S, Shibata J, Muta R, Ashihara H, Tanaka M, Fujiyama S, Tomita K (2004) Transcatheter arterial chemotherapy with and without embolization in patients with hepatocellular carcinoma. Oncology 66:24-31
31. Rand T LC, Schoder M, Schmook MT, Peck-Radosavljevic M, Kettenbach J, Wolf FSB, Lammer J (2005) Arterial embolization of unresectable hepatocellular carcinoma with use of microspheres, lipiodol, and cyanoacrylate. Cardiovasc Intervent Radiol 28:313-318
32. Yu JS, Kim KW, Jeong MG, Lee DH, Park MS, Yoon SW (2002) Predisposing factors of bile duct injury after transcatheter arterial chemoembolization (TACE) for hepatic malignancy. Cardiovasc Intervent Radiol 25:270-274
33. Huang XQ, Huang ZQ, Duan WD, Zhou NX, Feng YQ (2002) Severe biliary complications after hepatic artery embolization. World J Gastroenterol 8:119-123
34. Kim HK, Chung YH, Song BC, Yang SH, Yoon HK, Yu E, Sung KB, Lee YS, Lee SG, Suh DJ (2001) Ischemic bile duct injury as a serious complication after transarterial chemoembolization in patients with hepatocellular carcinoma. J Clin Gastroenterol 32:423-427
35. Koniaris LG, Seibel JA, Geschwind JF, Sitzmann JV (2003) Can ethanol therapies injure the bile ducts? Hepatogastroenterology 50:69-72
36. Brown KT (2004) Fatal pulmonary complications after arterial embolization with 40-120 lm tris-acryl gelatin microspheres. J Vasc Interv Radiol 15:197-200
37. Stridbeck H, Lorelius LE (1985) Liver necrosis after hepatic dearterialization in pigs. Cardiovasc Intervent Radiol 8:50-53
38. Rand T, Loewe C, Schoder M, Schmook MT, Peck-Radosavljevic M, Kettenbach J, Wolf F, Schneider B, Lammer J (2005) Arterial embolization of unresectable hepatocellular carcinoma with use of microspheres, lipiodol, and cyanoacrylate. Cardiovasc Intervent Radiol 28:313-318